Characteristics of individuals aged 15 to 22 years with SCD who completed the ASH SCD transition readiness assessment tool and those who did not
. | 15-22 years (N = 205), n (%) . | With assessment (n = 84), n (%) . | No assessment (n = 121), n (%) . | P value . |
---|---|---|---|---|
Sex, female | 109 (53) | 46 (55) | 63 (52) | .70 |
SVI∗ | ||||
Not very high (1) ≤0.75 | 26 (14) | 10 (12.2) | 16 (15.4) | .53 |
Very high (2) >0.75 | 160 (86) | 72 (87.8) | 88 (84.6) | |
SCD type† | ||||
Hemoglobin SS/Sβ0 thalassemia (1) | 94 (54.7) | 49 (63.6) | 45 (47.4) | .03 |
Others (0) | 78 (45.3) | 28 (36.4) | 50 (52.6) | |
Visits to pediatric SCD specialty clinic, median (interquartile range) | 0 (0-3) | 3 (1-4) | 0 (0-0) | <.0001 |
. | 15-22 years (N = 205), n (%) . | With assessment (n = 84), n (%) . | No assessment (n = 121), n (%) . | P value . |
---|---|---|---|---|
Sex, female | 109 (53) | 46 (55) | 63 (52) | .70 |
SVI∗ | ||||
Not very high (1) ≤0.75 | 26 (14) | 10 (12.2) | 16 (15.4) | .53 |
Very high (2) >0.75 | 160 (86) | 72 (87.8) | 88 (84.6) | |
SCD type† | ||||
Hemoglobin SS/Sβ0 thalassemia (1) | 94 (54.7) | 49 (63.6) | 45 (47.4) | .03 |
Others (0) | 78 (45.3) | 28 (36.4) | 50 (52.6) | |
Visits to pediatric SCD specialty clinic, median (interquartile range) | 0 (0-3) | 3 (1-4) | 0 (0-0) | <.0001 |